Prevalence of Chronic Kidney Disease in Lafia, North Central Nigeria

Main Article Content

Aminat Suleman-Alabi
Sadiq Maifata
Aminat ANURA
Ahmed RABIU
Elizabeth Ayoola

Abstract

Background: Chronic kidney disease (CKD) is a growing global public health problem associated with increased morbidity, mortality, and health-care costs. The burden of CKD is disproportionately higher in low- and middleincome countries, where access to early detection and renal care is often limited. In Nigeria, population-based data on CKD prevalence remain scarce, particularly in North Central regions such as Lafia. This study aimed to determine the prevalence of CKD and describe selected demographic and health-care access characteristics among adults in Lafia, Nigeria.
Methods: This cross-sectional study enrolled 190 participants aged 18 years and above. Serum creatinine was measured using Jaffe’s method, and estimated glomerular filtration rate (eGFR) was calculated using the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. CKD was defined as an eGFR <60 mL/min/1.73 m².
Results: The overall prevalence of CKD in the study population was 13.7%. Participants with CKD had a mean age of 39.4+3.1 years. The prevalence of CKD was higher in females compared with males. Only 61.6% of participants reported having access to a health-care facility.
Conclusions: This study demonstrates a relatively high prevalence of CKD (13.7%) among adults in Lafia, North Central Nigeria, with a notable burden observed in younger individuals. Limited access to health-care services may further exacerbate underdiagnosis and late presentation. These findings highlight the urgent need for community-based screening programs and improved access to healthcare services.

Article Details

How to Cite
Suleman-Alabi , A. ., Maifata, S., ANURA, A., RABIU, A., & Ayoola, E. . (2026). Prevalence of Chronic Kidney Disease in Lafia, North Central Nigeria. Journal of the Nephrology Society of Thailand, 32(1), 74–77. https://doi.org/10.63555/jnst.2026.284247
Section
Short Communication

References

Center for Disease Control and Prevention. chronic kidney disease. Available at: https://www.cdc.gov/kidneydisease/basics.html 2023: Accessed: 23rd May. 2024

Eguiguren-Jiménez L, Miles J, Ocampo J, Andrade JM. Prevalence and associated risk factors of chronic kidney disease: A case study within SIME clinics in Quito, Ecuador 2019-2021. Front Med 2022;9, 908551. doi: 10.3389/fmed.2022.908551

Hill NR. Fatoba ST, Oke JL, Hirst JA, O’Callaghan, CA, Lasserson DS, Hobbs FR. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one, 2016;11(7),e0158765. doi: 10.1371/journal.pone.0158765

Chukwuonye II, Ogah OS, Anyabolu EN, Ohagwu KA, Nwabuko OC, Onwuchekwa U, Chukwuonye ME, Obi EC, Oviasu E. Prevalence of chronic kidney disease in Nigeria: Systematic review of population-based studies. Int J Neph Renovas Dis 2018;11, 165. doi: 10.2147/ijnrd.s162230

Olanrewaju TO, Aderibigbe A, Popoola AA, Braimoh, KT, Buhari MO, Adedoyin OT, Kuranga SA, Biliaminu SA, Chijioke A, Ajape A., Grobbee DE, Blankestijn PJ, Klipstein-Grobusch K, & Ilorin Renal Study Group. Prevalence of chronic kidney disease and risk factors in North-Central Nigeria: a population-based survey. BMC nephrol 2020;21(1), 467. doi: 10.1186/s12882-020-02126-8

Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151-164. doi: 10.1038/nrneph.2017.181

Lewandowski MJ, Krenn S, Kurnilowski A, Bretschneider P, Sattler M, Schwaiger E, Antlanger M, Gauckler P, Pirklbauer M, Brunner M, Horn S, Zitt E, Kirsch B, Windpessl M, Wallner M, Aringer I, Wiesholzer M, Hecking M, Hodlmoser S. Chronic kidney disease is more prevalent among women but more men are under nephrological care: Analysis from six outpatient clinics in Austria 2019. Wien Klin Wochenschr 2023;135(3-4):89-96. doi: 10.1007/s00508-022-02074-3